Exchange: NASDAQ·Updated 04:07 PM EST

GERN News

News
all
press releases
Insider Buying: Geron (NASDAQ:GERN) EVP Acquires $11,280.00 in Stock
Geron Corporation (NASDAQ:GERN - Get Free Report) EVP Timothy Williams bought 12,000 shares of the stock in a transaction on Monday, November 16th. The shares were acquired at an average cost of $0.94 per share, for a total transaction of $11,280.00. Following the completion of the transaction, the...
MarketBeat
Insider Buying: Geron (NASDAQ:GERN) EVP Acquires $11,280.00 in Stock
Geron Corporation (NASDAQ:GERN - Get Free Report) EVP Timothy Williams bought 12,000 shares of the stock in a transaction on Monday, November 16th. The shares were acquired at an average cost of $0.94 per share, for a total transaction of $11,280.00. Following the completion of the transaction, the...
MarketBeat
More News
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Geron (GERN) delivered earnings and revenue surprises of +100.00% and +0.37%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Oct. 13, 2026Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation...
PR Newswire
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into Geron Corporation (Geron or the Company) (NasdaqGS: GERN).Throughout 2024, the Company touted the revenue outlook and...
Business Wire
Reblozyl's strong growth is helping Bristol Myers offset declining legacy drug sales, with new indications offering further upside.
Zacks
Human clinical development is putting one of aging biology’s most closely watched proteins on the biotechnology radar   New York, NY – September 30, 2026 – Klotho is quickly becoming one of the more interesting names in longevity research. What started largely as a research question around aging and biological decline is now moving closer […] The post Klotho Protein Emerges as a Potential Powerhouse In the Next Generation of Longevity Medicine appeared first on Financial News Media.
Financial News Media
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Sept. 25, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or...
PR Newswire
Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERNPR NewswireNEW YORK and NEW ORLEANS, Sept. 25, 2026 NEW...
PR Newswire
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into Geron Corporation (Geron or the Company) (NasdaqGS: GERN). Throughout 2024, the Company touted the revenue outlook and...
Business Wire

Advertisement|Remove ads.